Biohaven Therapeutics Ltd.

This study looks at whether the drug troriluzole can slow the worsening of spinocerebellar ataxia (SCA), a rare brain disease that affects movement. Researchers compared 909 patients who took troriluzole for up to 3 years to similar patients who did not receive the drug. The goal…

This study tests an investigational drug called taldefgrobep alfa to help adults with overweight or obesity lose weight. About 150 participants receive either the drug or a placebo injection weekly for 24 weeks, with an option to continue in an open-label extension. The main goal…

This study checks the long-term safety of an experimental drug called BHV-7000 in adults whose focal epilepsy does not get better with current treatments. About 660 people who finished a previous study will take the drug and be watched for side effects. The goal is to see if the …

This study tests a new drug, BHV-7000, to see if it can reduce chronic pain in people with inherited erythromelalgia, a rare genetic condition that causes severe burning pain. Five adults with a specific gene mutation will receive both the drug and a placebo in a crossover design…